AstronauTx completes £48m series A financing for Alzheimer’s disease
The financing will support the biotech’s clinical study of people with AD as a lead programme
Read More
Tag: Novartis Venture Fund
UK’s Enterprise Therapeutics raises £29m
Brighton, UK-based Enterprise Therapeutics has raised £29 million to help it advance its experimental therapies for respiratory diseases.
Read More
- ErVimmune raises 17m euros in funding to develop cancer vaccine
- Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
